Bill Ackman, the activist fund manager, has attempted to draw a line under his ill fated association with Valeant, agreeing to pay $m to settle claims that he profited from insider trading in the duo s attempted takeover of Allergan. In a statement on Friday, Pershing Square Holdings, the London listed .Meanwhile, the fat settlement looks paltry next to the scope of the accusations. Allergan investors sued Pershing Square and Valeant Pharmaceuticals in , alleging that Ackman s fund reaped $. billion in illicit profits in Allergan stock by trading on inside information from Valeant when the .Ackman agrees $m settlement over Allergan trading claims Financial TimesBill Ackman just took a $ million hit to his reputation Business InsiderPershing Square, Valeant to Pay $ Million to End Lawsuit BloombergFull coverage Source link..Ackman agrees $m settlement over Allergan trading claims. Pershing Square and Valeant were accused of improper trading ahead of bid for Botox maker. Previous Article Brookfield moves into private rented sector for fresh profit. Next Article Hedge fund mogul Steve Cohen plans comeback in .